News & Press

June 1, 2022

Strategic Investment Increases xRNA-based LNP Formulation Services at Caponago Injectable Facility

June 1, 2022
Press Release > CordenPharma Invests in xRNA-based LNP Formulation Services at its Caponago Injectable Facility.

May 2, 2022

Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG

May 2, 2022
Press Release > Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG.

April 13, 2022

CordenPharma Receives Supplier Recognition Award from Esperion

April 13, 2022
CordenPharma Receives Supplier Recognition Award from Esperion at DCAT Week 2022.

April 11, 2022

CordenPharma and WACKER To Produce mRNA Vaccines for Germany When Needed

April 11, 2022
Press Release > Wacker & CordenPharma win contract to be stand-by ready to produce mRNA vaccines for German government if needed.

March 14, 2022

CEO Discusses CDMO Capex Growth & Expansion in 2022

Edition 1 / March 2022
CEO Editorial > 2022 & Beyond: Resiliency, Expansion & Growth

March 14, 2022

Corden Connect Interviews New Managing Director Yvan Liard of CordenPharma Fribourg

Edition 1 / March 2022
New Facility Acquisition Video Series > Part 1: Interview with Managing Director Yvan Liard of CordenPharma Fribourg

March 14, 2022

Three New Drug Product Facilities Expand Small Molecules Platform

Edition 1 / March 2022
Small Molecules Platform > Three New Drug Product Facilities Expand & Augment Our Small Molecules Platform

March 14, 2022

LNP Formulation Process Capability Expansion in Caponago

Edition 1 / March 2022
Lipid & Injectable Platforms > New Lipid NanoParticle Formulation Capabilities Bring Flexible Drug Development Options

March 10, 2022

CordenPharma Donates to Support Disaster Relief Efforts in the Ukraine

March 10, 2022
CordenPharma donates a combined €100,000 to support disaster relief efforts in the Ukraine.

March 3, 2022

CEO Michael Quirmbach Talks Expanded Footprint, Green Chemistry & Growth

March 3, 2022
Global Business Reports Interview: CEO Michael Quirmbach Talks 2022 Expanded Footprint & Growth Strategy

March 1, 2022

CordenPharma Chenôve Increases Lipid Manufacturing Capacity to Support mRNA Vaccines

March 1, 2022
Press Release > CordenPharma Chenôve Increases Lipid Manufacturing Capacity to Support mRNA Vaccine Strategy.

January 26, 2022

CordenPharma Completes Acquisition of 3 Facilities from Vifor Pharma

February 1, 2022
Press Release > CordenPharma Completes Acquisition of 3 Facilities from Vifor Pharma

January 18, 2022

CordenPharma Collaborates on Continuous Peptide Manufacturing & Green Chemistry

January 18, 2022
Press Release > CordenPharma Collaborates with PeptiSystems on Green Continuous Peptide Manufacturing.

January 13, 2022

DCAT Value Chain Insights Interviews CEO Michael Quirmbach on 2022 CDMO Key Issues

January 13, 2021
DCAT Value Chain Insights Interview: CEO Michael Quirmbach Talks Trends & Issues in the CDMO Sector for 2022.

December 16, 2021

CordenPharma to Acquire Three Drug Product Manufacturing Facilities from Vifor Pharma

December 16, 2021
Press Release > CordenPharma to Acquire Three Drug Product Manufacturing Facilities from Vifor Pharma

Name	_ga
Provider	google-analytics.com
Purpose	This cookie name is associated with Google Universal Analytics - which is a significant update to Google's more commonly used analytics service. This cookie is used to distinguish unique users by assigning a randomly generated number as a client identifier. It is included in each page request in a site and used to calculate visitor, session and campaign data for the sites analytics reports.
Cookie life cycle	2 years

Name	_gid
Provider	google-analytics.com
Purpose	This cookie is set by Google Analytics. It stores and update a unique value for each page visited and is used to count and track pageviews.
Cookie life cycle	1 Day

Name	collect
Provider	google-analytics.com
Purpose	"Used to send data to Google Analytics about the visitor's device and behavior. Tracks the visitor across devices and marketing channels.
Cookie life cycle	session

Name	vuid
Provider	vimeo.com
Purpose	Collects data on the user's visits to the website, such as which pages have been read. These cookies are used by the Vimeo video player on websites.
Cookie life cycle	2 years

Name	BE_CLA3
Provider	BrightEdge
Purpose	Enables data aggregation, analysis and report creation to assess marketing effectiveness and for website performance.
Cookie life cycle	37199 days

Strategic Investment Increases xRNA-based LNP Formulation Services at Caponago Injectable Facility

Astorg to Acquire Leading Pharmaceutical CDMO CordenPharma from ICIG

CordenPharma Receives Supplier Recognition Award from Esperion

CordenPharma and WACKER To Produce mRNA Vaccines for Germany When Needed

CordenPharma Donates to Support Disaster Relief Efforts in the Ukraine

CEO Michael Quirmbach Talks Expanded Footprint, Green Chemistry & Growth

CordenPharma Chenôve Increases Lipid Manufacturing Capacity to Support mRNA Vaccines

CordenPharma Completes Acquisition of 3 Facilities from Vifor Pharma

CordenPharma Collaborates on Continuous Peptide Manufacturing & Green Chemistry

DCAT Value Chain Insights Interviews CEO Michael Quirmbach on 2022 CDMO Key Issues

CordenPharma to Acquire Three Drug Product Manufacturing Facilities from Vifor Pharma

Essential

Statistics

Marketing

Name	__utmc
Provider	google-analytics.com
Purpose	This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour and measure site performance. It is not used in most sites but is set to enable interoperability with the older version of Google Analytics code known as Urchin. In this older versions this was used in combination with the __utmb cookie to identify new sessions/visits for returning visitors. When used by Google Analytics this is always a Session cookie which is destroyed when the user closes their browser. Where it is seen as a Persistent cookie it is therefore likely to be a different technology setting the cookie.
Cookie life cycle	Session

Name	__utmt
Provider	google-analytics.com
Purpose	This is one of the four main cookies set by the Google Analytics service which enables website owners to track visitor behaviour and measure site performance. This cookie determines new sessions and visits and expires after 30 minutes. The cookie is updated every time data is sent to Google Analytics. Any activity by a user within the 30 minute life span will count as a single visit, even if the user leaves and then returns to the site. A return after 30 minutes will count as a new visit, but a returning visitor.
Cookie life cycle	30 minutes

Name	Google Maps API
Provider	Google Maps
Purpose	to read user IP address.
Cookie life cycle	expires immediately

Name	GPS
Provider	Youtube
Purpose	YouTube is a Google owned platform for hosting and sharing videos. YouTube collects user data through videos embedded in websites, which is aggregated with profile data from other Google services in order to display targeted advertising to web visitors across a broad range of their own and other websites.
Cookie life cycle	session